Intelligence Platform
Patents
Browse 3,063 pharma-relevant patents (US and EP, A61K/A61P) linked to tracked companies. Patent cliff and LOE intelligence for BD teams.
US 8765141
Development of a marker foot and mouth disease virus vaccine candidate that is attenuated
granted patentUS 8759014
Methods of obtaining antigen-specific T cell populations
granted patentUS 8754046
MHC class II restricted T cell epitopes from the cancer anitgen, NY ESO-1
granted patentUS 8754081
Compositions and methods for inhibition of hepatocyte growth factor receptor c-Met signali
granted patentUS 8753649
Polysaccharide-protein conjugate vaccines
granted patentUS 8754030
Defensin-antigen fusion proteins
granted patentUS 8748390
Immunogenic epitopes of NGEP antigen
granted patentUS 8748572
RNase a peptides, fragments and uses thereof
granted patentUS 8748114
ZAP-70 expression as a marker for chronic lymphocytic leukemia / small lymphocytic lymphom
granted patentUS 8748608
4-phenylpiperazine derivatives with functionalized linkers as dopamine D3 receptor selecti
granted patentUS 8747823
Compositions and methods for treating a keratin based substrate
granted patentUS 8747859
Porcine reproductive and respiratory syndrome vaccine based on isolate JA-142
granted patentUS 8747863
Vaccine for shigella
granted patentUS 8741313
Polypeptide vaccine and vaccination strategy against mycobacterium
granted patentUS 8741649
Methods for enhancing genome stability and telomere elongation in embryonic stem cells
granted patentUS 8741869
Oligodeoxynucleotide and its use to induce an immune response
granted patentUS 8741947
Biologically active macrolides, compositions, and uses thereof
granted patentUS 8741309
Porcine reproductive and respiratory syndrome vaccine based on isolate JA-142
granted patentUS 8735082
Gene signature for predicting prognosis of patients with solid tumors
granted patentUS 8735126
Disease control with tick phospholipase A2
granted patentUS 8735355
Methods of use of fragments of secreted frizzled related protein, sFRP
granted patentUS 8735369
Compositions and methods for inhibiting expression of a gene from the Ebola virus
granted patentUS 8735407
Purine derivatives as A3 adenosine receptor-selective agonists
granted patentUS 8728526
Coacervate microparticles useful for the sustained release administration of therapeutic a
granted